Benefiber Fiber Supplement Plus Calcium (Novartis) – Consumer Complaints (2013)
Class II: A situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Class II recall indicates potential for temporary health effects.
This AI-generated summary is provided for general informational purposes only and is derived from publicly available recall notices. It supplements but does not replace official agency classifications or safety instructions.
Check Your Product
According to the U.S. Food and Drug Administration (FDA)
Product
Benefiber Fiber Supplement Plus Calcium, Orange Natural Flavor, Sugar Free, packaged in 10.76-oz (48 Servings) bottles, UPC 300670108489. Distributed by: Novartis Consumer Health, Inc., Parsippany, NJ 07054-0622. Made in France.
Brand
Novartis Consumer Health
Lot Codes / Batch Numbers
10102129, 10102130, 10102131, 10104656, 10104657, 10104658, 10104659, 10107484, 10114954, 10124211, and 10125514
Products Sold
10102129, 10102130, 10102131, 10104656, 10104657, 10104658, 10104659, 10107484, 10114954, 10124211, and 10125514
Novartis Consumer Health is recalling Benefiber Fiber Supplement Plus Calcium, Orange Natural Flavor, Sugar Free, packaged in 10.76-oz (48 due to The products are being recalled due to the receipt of a relatively high number of consumer complaints.. This is a Class I recall, indicating a high risk of serious health consequences. Based on FDA enforcement report.
Summary derived from FDA notice
Reason for Recall
As stated by FDA
The products are being recalled due to the receipt of a relatively high number of consumer complaints.
Recommended Action
Per FDA guidance
Consumers should stop using the product and contact the recalling firm or return it to the place of purchase.
Verify this information on the official source
For complete details and official instructions, check the U.S. Food and Drug Administration (FDA) directly.
View official FDA recall noticePage updated: Jan 6, 2026